Condition: Liver Disease Chronic · HEPATITIS C VIRUS CHRONIC INFECTION · Sponsor: University of Guadalajara
The purpose of this clinical trial is to evaluate whether a nutritional supplement containing resveratrol, quercetin, taurine, inulin, and whey protein improves biochemical and molecular markers, as well as clinical outcomes, in patients with liver disease related to chronic hepatitis C infection. The study will compare the investigational supplement with an active control (whey protein alone) to determine whether the combination formulation provides additional benefits on liver-related biomarkers and clinical assessment. Participants will: Take the investigational supplement or active control daily for 12 weeks. Attend clinic visits every 4 weeks for laboratory testing and clinical evaluations.
This description comes directly from the study's public registry record.
Juan Roberto Rodriguez-Echevarria, PhD · +52 33 18 23 13 10 · roberto.rodriguez@academico.udg.mx
Always discuss trial participation with your own doctor first.
| Hospital Civil de Guadalajara Fray Antonio Alcalde | Guadalajara, Jalisco, Mexico | Recruiting |
| Hospital Civil de Guadalajara Fray Antonio Alcalde | Guadalajara, Jalisco, Mexico | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07487623